Sen. Susan Collins (R-Maine) slammed the National Institutes of Health’s decision to slash billions of dollars in “indirect” costs for biomedical research funding, calling the move mandated by the Trump administration “devastating” and a “poorly conceived directive.”

Amid a historically unprecedented barrage of executive orders, the key question is: Does the president have the power to change how federal funding is spent with a single stroke of a pen?

A super PAC aligned with congressional Democrats is identifying 9 vulnerable GOP incumbents who represent lots of farmers impacted by the freeze.